Meme stocks: Data providers conflicted on offering investment analyses

While some alternative data providers are jumping in on the meme-stock craze by producing new datasets and analyses geared toward risk management and alpha generation, others—perhaps rightly so—are staying cautious.

What’s old is new again. As Covid-19 pandemic-induced lockdowns finally ease, and citizens reacquaint themselves with their former haunts, a Forbes’ 1998 cover—which declared “A bunch of kids are tormenting Wall Street!”—could have been written yesterday.

A heated national conversation about so-called “meme stocks” has been ongoing among US investors, traders, legislators, and the average online Joes and Janes for six months, a result of the January 28 fiasco, in which video game retailer

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Northern Trust building internal cloud data ‘marketplace’

Using a mix of in-house expertise and third-party technologies, the firm has constructed a cloud-based data mesh that gives internal staff access to proprietary datasets and analytical tools to deliver greater insights into client activity.

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here